Related Experiment Video
Updated: Feb 24, 2026
04:22
Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
Published on: May 30, 2025
1.1K
Priapism due to essential thrombocythaemia: a rare causation
Sunny Goel1, Ashok Kumar Sokhal1, Bhupendra Pal Singh1
1Department of Urology, King George's Medical University, Lucknow, Uttar Pradesh, India.
BMJ Case Reports
|August 22, 2017
Summary
Priapism, a prolonged erection, can rarely stem from essential thrombocythemia (a condition with excess megakaryocytes). This case highlights a young man whose priapism was caused by this rare blood disorder.
Area of Science:
- Hematology
- Urology
Background:
- Essential thrombocythemia is a myeloproliferative neoplasm characterized by an overproduction of megakaryocytes.
- Priapism is a medical emergency typically associated with hematological disorders like sickle cell disease, but rarely with essential thrombocythemia.
Observation:
- A 21-year-old male presented with priapism.
- Initial investigations were conducted to determine the underlying cause of the priapism.
Findings:
- The patient was diagnosed with essential thrombocythemia.
- Essential thrombocythemia was identified as the direct cause of the priapism in this case.
Implications:
- This case underscores the importance of considering rare hematological causes for priapism.
- Early diagnosis and management of essential thrombocythemia are crucial to prevent complications associated with priapism.
Related Concept Videos
01:30Venous Thrombosis I: Introduction
535
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
535
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.1K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.1K
01:28Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
653
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
653
01:30Pulmonary Hypertension: Classification and Pathogenesis
703
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
703
01:30Peripheral Artery Disease I: Introduction
451
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
451
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
506
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
506